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Abstract
Several of the infectious diseases associated with human lice are life-threatening, including epidemic typhus, relapsing fever, and trench
fever, which are caused by Rickettsia prowazekii, Borrelia recurrentis, and Bartonella quintana, respectively. Although these diseases have
been known for several centuries, they remain a major public health concern in populations living in poor-hygiene conditions because of
war, social disruption, severe poverty, or gaps in public health management. Poor-hygiene conditions favour a higher prevalence of body
lice, which are the main vectors for these diseases. Trench fever has been reported in both developing and developed countries in pop-
ulations living in poor conditions, such as homeless individuals. In contrast, outbreaks of epidemic typhus and epidemic relapsing fever
have occurred in jails and refugee camps in developing countries. However, reports of a significantly high seroprevalence for epidemic
typhus and epidemic relapsing fever in the homeless populations of developed countries suggest that these populations remain at high
risk for outbreaks of these diseases. Additionally, experimental laboratory studies have demonstrated that the body louse can transmit
other emerging or re-emerging pathogens, such as Acinetobacter baumannii and Yersinia pestis. Therefore, a strict survey of louse-borne
diseases and the implementation of efficient delousing strategies in these populations should be public health priorities.
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Introduction
There are more than 3000 species of lice. Among these,
humans constitute the preferred host for only two species:
Pediculus humanus and Phthirus pubis (pubic lice). P. humanus
includes two morphotypes, P. humanus morphotype capitis
(head lice) and P. humanus morphotype corporis (body lice)
[1]. Head, body and pubic lice live on the head, in clothing,
and in the pubic area, respectively. It has been suggested that
the head louse is the ancestor of P. humanus, and that the
body louse originated from the head louse when humans
began to wear clothes [2]. In addition, it has been recently
proposed that humans with both poor hygiene and head
louse infestations provide an opportunity for head louse vari-
ants to ingest a greater amount of blood, colonize clothing,
and differentiate into body lice [3]. Louse infestations have
been prevalent among humans for thousands of years [4],
and they still affect hundreds of millions of people worldwide
each year [5]. In this article, we review the transmissible
infectious diseases associated with human louse infestation.
Epidemiology of Human Lice
The louse life cycle begins when a female louse lays eggs,
called nits, on hair follicles, folds of clothing, or on the base
of the pubic hair shaft, according to the species of louse. A
female louse lays approximately eight eggs a day, and can lay
up to 300 eggs during her lifetime. In a favourable environ-
ment with a constant temperature, eggs will hatch after
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6–10 days into nymphs. Lice mature into adults after
10 days, and live for approximately 1–3 months. Lice are
obligate host-specific blood-sucking insects that typically feed
five times a day. When head and body lice are separated
from their host, they die in less than 24 h and 48 h, respec-
tively. Humidity and temperature are also critical for louse
survival. For example, body lice prefer humidity ranging from
70% to 90%, and temperatures between 29C and 32C;
they cannot survive when humidity drops below 40% or
when the temperature is greater than 50C [6,7].
Clinical Characteristics of Louse
Infestations
Louse infestation, called pediculosis, is very contagious and
easily transmitted by close body-to-body contact or contact
with infested linen, brushes, or clothes, according to the spe-
cies of louse. Pediculosis capitis, caused by head lice, is the
most common louse infestation; it particularly affects school-
children 3–11 years of age [5]. It has been demonstrated that
pediculosis capitis is associated with low socio-economic sta-
tus of the parents (unemployed or manual workers), family
size (four or more children), and clustering of children in
classes and schools [8]. Its clinical hallmark is scalp pruritus.
Diagnosis is established by the identification of viable adult
lice, nymphs or, more easily, of nits glued to the hair on the
scalp (Fig. 1) [5]. Pediculosis corporis, caused by body lice,
represents a major public health concern. It is strongly asso-
ciated with close body-to-body contact, and occurs only
when clothes are not changed or washed regularly. These
conditions are more prevalent in individuals living in crowded
and unhygienic environments, such as refugee camps or shel-
ters for the homeless [5–7]. During the civil wars in Burundi,
Rwanda and Zaire in the 1990s, the prevalence of louse
infestations reached 90–100% [9]. In sheltered homeless
populations in developed countries, the reported prevalence
of body louse infestation ranged from 11% to 22% [10,11],
with rates up to 80% being observed in the poorest-hygiene
conditions. Clinical manifestations include generalized pruri-
tus associated with scratching; lesions are typically localized
to the neck, thorax, waist, and ankles [5]. Diagnosis is based
on a finding of adult lice and, more importantly, eggs in
clothing seams (Fig. 2). Simultaneous infestation with both
head and body lice has been recently reported in 4.3% of
homeless individuals seen in emergency settings in San Fran-
cisco, CA [12], and in 59% of street children in Nepal [13].
Pubic lice are typically transmitted sexually, and transmission
cannot be prevented by condom use. Pubic infestation pre-
dominantly results in pubic itching [5].
Louse-borne Infectious Diseases
Of the three types of louse that affect humans, only body
lice act as vectors for human pathogens. Body lice are
known to transmit epidemic typhus, relapsing fever, and
trench fever, diseases caused by Rickettsia prowazekii, Borrelia
recurrentis, and Bartonella quintana, respectively [6,7]. These
three pathogens have been recovered experimentally in body
louse faeces [6,14,15], suggesting that the transmission of
these organisms occurs through the contamination of bite
sites, conjunctivae, and mucous membranes, either by faeces
from infected body lice or by crushed infected louse bodies.
Louse-borne diseases are associated with a high prevalence
of body louse infestation, and have recently re-emerged in
jails and refugee camps in central and eastern Africa [9], in
FIG. 1. Nits glued to the hair on the scalp. The immature lice are
seen through the nit membrane. Inverted light microscope. FIG. 2. Body lice and eggs in clothing seams.
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rural communities in the Peruvian Andes [16], in rural louse-
infested populations in Russia [17], and in homeless popula-
tions living in poor-hygiene conditions in developed countries
[10,11,18–20]. Head and pubic lice have been found to be
competent vectors in laboratory settings [6,21]. B. quintana
DNA has been detected in head lice from Nepalese slum
children [22], Ethiopian street beggars [23], and homeless
adults in San Francisco [12]. It has also been detected in
head louse nits from a homeless man in Marseilles (France)
[24]. However, B. quintana DNA was not detected in head
lice collected from schoolchildren in France and seven other
countries [25,26]. Factors contributing to the presence of
B. quintana in head lice are debated [25], and could include
genotype C head lice and high altitude (‡2121 m) [23,27].
Currently, head and pubic lice are not considered to be vec-
tors for human pathogens.
Epidemic typhus
Epidemic typhus is caused by R. prowazekii, an obligate intra-
cellular bacterium. The mortality rate of epidemic typhus
varies from 0.7% to 60% for untreated cases. Lice become
infected with R. prowazekii when they feed on bacteraemic
individuals; however, lice die within 1 week after becoming
infected. Humans with self-limiting infections that fail to clear
the bacteria and exhibit bacterial persistence in adipose tis-
sue endothelial cells constitute the main reservoir of R. prow-
azekii [6,28]. Under stress, infection recrudescence can
occur years after the primary infection, resulting in a rela-
tively mild bacteraemic illness called Brill–Zinsser disease.
Infection recrudescence can initiate the re-emergence of a
focused epidemic if body louse infestations are prevalent
[6,28]. In the USA, R. prowazekii has also been isolated in fly-
ing squirrels, Glaucomys volans volans, indicating the existence
of another reservoir [29]. However, the mechanism by
which R. prowazekii is transmitted from flying squirrels to
humans remains unknown. Inhalation of aerosolized infected
faeces from lice of flying squirrels has been suggested
[28,29]. Outbreaks of epidemic typhus have generally been
associated with war, famine, refugee camps, cold weather,
and gaps in public health management. Recent outbreaks of
epidemic typhus were reported in the 1990s in Burundi and
Russia [9,17]. No outbreaks of epidemic typhus have been
recently identified in wealthy developed countries. However,
a case of Brill–Zinsser disease [30], a sporadic case of
imported typhus from Algeria [31], significantly high anti-
R. prowazekii antibody titres within a homeless population
[18] and an autochthonous case of epidemic typhus in a
homeless individual [32] have been reported in Marseilles,
France. Anti-R. prowazekii antibodies were also detected in
the sera of two of 176 homeless individuals assessed in
Houston, Texas [33]. These reports suggest that the disease
is likely to re-emerge at any time in homeless populations.
Epidemic typhus is a life-threatening, acute exanthematic
febrile illness with a broad range of clinical manifestations
[9,28]. Any severe outbreak of an unexplained fever in unhy-
gienic environments, such as jails, chronically poor countries,
and cold countries, or during civil wars, social collapses, and
natural disasters, may indicate epidemic typhus. After an
incubation period of 10–14 days, patients usually experience
1–3 days of malaise associated with fever and multiple painful
symptoms, which are then followed by the development of
rashes (20–40% of patients), neurological manifestations
(80%), respiratory manifestations (38–70%), and shock (7%).
Relevant laboratory findings include thrombocytopaenia
(40%), elevated transaminase levels (63%), and renal dysfunc-
tion. In the pre-antibiotic era, the mortality rates were esti-
mated to reach up to 60%; currently, the mortality rate is
approximately 4% in correctly treated patients. In the most
extreme situations of malnutrition, mortality rates higher
than 50% may occur [28]. Patients with Brill–Zinsser disease
exhibit milder clinical manifestations and a shorter disease
duration. However, death can occur in some cases [6,28].
Epidemic typhus is microbiologically diagnosed with a
serology-based microimmunofluorescence test for the detec-
tion of rickettsial antibodies, and western blot analysis com-
bined with cross-adsorption tests for the distinction between
R. prowazekii and Rickettsia typhi. Patients with Brill–Zinsser
disease have increased IgG antibodies to R. prowazekii but
have no specific IgM antibodies. Other diagnostic methods
include culture with a shell-vial assay that can be used to iso-
late R. prowazekii from clinical specimens (blood or skin
biopsy) and quantitative real-time PCR assays that target the
R. prowazekii-specific gltA gene. This PCR technique can be
utilized to assess samples from various sources [28].
Treatment of epidemic typhus is based on the administra-
tion of tetracycline and chloramphenicol. Treatment for
5 days (or for 2–4 days after defervescence) has been rec-
ommended [28] for each antibiotic. In outbreak situations, a
single 200-mg oral dose of doxycycline can be effective [9].
Epidemic relapsing fever
Epidemic relapsing fever is a louse-borne infection caused by
the spirochete Borrelia recurrentis that affected several million
people worldwide during the first half of the 20th century,
particularly during the world wars [6]. Although it has disap-
peared in many regions around the world, it is still a major
public health concern in northern and eastern Africa [6,34].
It is the seventh most common cause (up to 27%) of hospital
admission and the fifth most frequent cause of death in the
highlands of Ethiopia [35]. Antibodies against Borrelia recurrentis
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have also been detected in a rural Andean community in
Peru [16]. Additionally, we observed a significant increase in
the prevalence of anti-Borrelia recurrentis antibodies in home-
less populations in Marseille in 2002, suggesting that a small,
unnoticed outbreak occurred in this population [18]. As with
epidemic typhus, relapsing fever predominantly affects
populations living in poor-hygiene conditions where body
louse infestations are prevalent [6,18].
Humans constitute the only known reservoir and host of
Borrelia recurrentis. After becoming infected by ingesting an
infected blood meal, a louse remains infected throughout its
lifetime; however, it cannot transmit Borrelia to its progeny.
Modes of Borrelia recurrentis transmission are similar to those
for R. prowazekii. However, Borrelia recurrentis is able to pen-
etrate and infect intact mucosa and skin surfaces [6].
The illness begins abruptly with a high-grade fever, pain,
anorexia, dry cough, and fatigue. Complications can occur,
including skin and mucosal haemorrhaging; neurological,
liver and renal involvement; and spleenic rupture. Jaundice
is a diagnostic clue that suggests relapsing fever among
louse-borne diseases [6]. Following a primary potentially
fatal episode, the disease is predominantly characterized by
a series of relapses that are less severe and shorter in
duration, and occur at intervals of 7 or 10 days. Common
diagnostic methods include the detection of Borrelia in
Giemsa-stained blood films and PCR assays. The death rate
varies from 10% to 40% in untreated patients, and from 2%
to 4% in patients treated with antibiotics such as doxycy-
cline or erythromycin. However, in up to 75% of patients,
treatment can result in the Jarish–Herxheimer reaction; this
reaction is particularly prevalent in patients over 14 years
of age [7].
Trench fever
Trench fever, which is caused by the facultative intracellular
Gram-negative bacterium B. quintana, is a old disease. B. quin-
tana DNA was detected in the dental pulp of a 4000-year-old
man [36]. Recent identification of B. quintana DNA in lice
found in a mass grave of Napoleon’s soldiers in Lithuania sug-
gests that many of the soldiers were affected by trench fever
[37]. The name ‘trench fever’ was chosen because the disease
was first described in both Allied and German troops crowded
into trenches during World War I [6]. It has been estimated
that trench fever affected several million people worldwide
during the two world wars, especially in Russia and on the
Eastern, Central and Western European fronts [6,7]. The inci-
dence of trench fever dramatically decreased after World War
II; however, in the early 1990s, it was recognized as a major
re-emerging infectious disease in urban homeless populations
of developed countries who have poor living conditions char-
acterized by extreme poverty, lack of hygiene, and exposure
to extremely low temperatures [9,18–20].
B. quintana is predominantly transmitted to humans by the
body louse via transmission routes similar to those of
R. prowazekii and Borrelia recurrentis [6]. Humans constitute
the natural reservoir of the bacterium, which persists in
erythrocytes and erythroblasts [38]. Nevertheless, B. quin-
tana has been recently detected in cat fleas, cat dental pulp,
and in a patient who owned a cat and sought treatment for
chronic adenopathy [39–41]; these findings suggest that
other possible vectors and transmission modes similar to
those of Borrelia henselae, the aetiological agent of cat scratch
disease, may exist. B. quintana was also detected by PCR in
Ixodes pacificus adult ticks collected in California [42]. The
endothelial cell tropism of B. quintana frequently results in
the development of angioproliferative lesions [6,43].
Trench fever results from a primary infection with B. quin-
tana [6,43]. The incubation period typically varies from 15 to
25 days, but can be reduced to 6 days in experimental infec-
tions. The most frequent presentation is the acute onset of a
high-grade fever, headache, dizziness, and characteristic shin
pain. The first fever episode can last for between 2 and
4 days. Occasionally, the primary episode is followed by a
relapse every 4-5 days, giving it the name of ‘quintan fever’.
Although trench fever often results in prolonged disability,
no deaths have been reported [6,43].
Other clinical presentations have been reported, including
chronic bacteraemia. We found chronic B. quintana bactaere-
mia in 5.4% of 930 sheltered homeless individuals in Marseille.
In our experience, chronic bacteraemia can last for up to
78 weeks [17,43]. A link between chronic bacteraemia and
endocarditis has not yet been established. However, B. quin-
tana endocarditis was first reported in three homeless men in
France [44]. It is most often observed in chronic alcoholic
homeless individuals who have been exposed to body lice and
do not have a previously described valvulopathy. Because the
disease is typically indolent and blood culture results are usu-
ally negative when stopped on day 8, diagnosis is often
delayed, resulting in a higher mortality rate than for infectious
endocarditis caused by other pathogens [43]. Bacillary angi-
omatosis is a vascular proliferative disease that most often
involves the skin; however, it can also involve other organs,
such as the spleen or liver. The disease was first described in
human immunodeficiency virus-infected patients and organ
transplant recipients, but in rare circumstances it can also
affect immunocompetent patients. Bacillary angiomatosis is
caused by both B. quintana and Borrelia henselae [6,43]. B. quin-
tana-induced lymphadenopathy has also been reported on the
basis of isolation of B. quintana from blood cultures and bone
marrow biopsies [41].
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The microbiological diagnosis of B. quintana infections can
be achieved through the use of serology-based indirect
immunofluorescence assays, molecular biological assays
(PCR), and immunohistochemical tests; for these serological
tests, western blot analysis and cross-adsorption are per-
formed to avoid cross-reactions with other Bartonella
species, Coxiella burnetii, and Chlamydia pneumoniae. When
B. quintana infection is suspected, serological testing (IgG
titres of >1/50 indicate Bartonella infection) and a blood cul-
ture should be performed. The most efficient culture
method for B. quintana isolation is subculturing of blood cul-
ture broth onto agar medium. Subcultures are usually posi-
tive by 14 days, but it can take as long as 45 days to obtain a
result [45]. When endocarditis is suspected (IgG titres of
>1/800), culture on shell vials, immunohistochemical tests
and PCR analysis should be performed on cardiac valve sam-
ples. These tests should be performed on skin biopsy speci-
mens when bacillary angiomatosis is suspected [43,45].
Antibiotic therapy for treatment of B. quintana in humans
is a challenge. The recommended regimen for patients with
chronic bacteraemia is a combination of gentamicin (3 mg/kg
intravenously once daily for 14 days) and doxycycline
(200 mg orally once daily) for 28 days; for patients with
endocarditis, this regimen is extended to 42 days [46].
Other Louse-associated Diseases
The role of body lice in the transmission of other bacterial
human pathogens is still under debate. Acinetobacter baumannii
DNA was detected in 21% of 622 lice collected worldwide
[47] and in 33% of head lice collected from 245 children in 44
schools in Paris (France) [25], demonstrating that this bacte-
rium is commonly found in human body lice. However, to
date, no A. baumannii infections transmitted by a body louse
have been reported. Since Yersinia pestis, the aetiological
agent of plague, was recovered from a body louse collected
from a septicaemic patient during a familial plague outbreak in
southern Morocco in the 1940s [48], the role of lice in plague
transmission has been strongly suspected. Although
louse-mediated plague transmission has been experimentally
demonstrated in our laboratory [49], direct louse-bite
transmission has yet to be demonstrated in humans; this mode
of transmission for plague needs to be further studied [7].
Delousing
The best way to control louse-borne diseases is delousing.
Efficient delousing methods include: regularly changing the
clothing, including underwear; boiling infested clothes and lin-
ens; and the use of insecticides and ivermectin for infected
persons. However, all of these methods were found to be
inefficient when applied to socio-economically deprived indi-
viduals living in homeless shelters, where delousing still
remains a challenge [7].
Conclusion
To date, there are three known louse-borne diseases: epi-
demic typhus, epidemic relapsing fever, and trench fever.
These infections particularly affect populations living in poor-
hygiene conditions where body louse infestations are preva-
lent. Whereas epidemic typhus and epidemic relapsing fever
are particularly prevalent in vulnerable populations in devel-
oping countries, trench fever is common worldwide, espe-
cially in homeless individuals. Regular surveys of these
populations and the implementation of efficient delousing
strategies are necessary to prevent major epidemics of
known louse-borne diseases or other potentially emerging
louse-borne pathogens, such as A. baumannii and Y. pestis.
Efficient delousing methods include regularly changing the
clothing, boiling infested clothes and linens, and the use of
insecticides and ivermectin for infected persons. In addition,
in an epidemic typhus outbreak, a single 200-mg oral dose of
doxycycline should be used.
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